These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 10941943)

  • 21. Prospective phase II trial of alternating intravesical Bacillus Calmette-Guérin (BCG) and interferon alpha IIB in the treatment and prevention of superficial transitional cell carcinoma of the urinary bladder: preliminary results.
    Bazarbashi S; Raja MA; El Sayed A; Ezzat A; Ibrahim E; Kattan S; Kardar A; Peracha A; Lindstedt E; Hanash K
    J Surg Oncol; 2000 Jul; 74(3):181-4. PubMed ID: 10951412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained prophylactic effect of intravesical bacille Calmette-Guérin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study.
    Hinotsu S; Akaza H; Isaka S; Kanetake H; Kubota Y; Kuroda M; Shinohara N; Shinka T; Tachibana M; Naito S; Hirao Y;
    Urology; 2006 Mar; 67(3):545-9. PubMed ID: 16527576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term effects on recurrence and mortality in superficial urothelioma of the bladder treated with endovesical chemotherapy].
    Ferraris V; Serao A; Buffa G
    Minerva Urol Nefrol; 1999 Jun; 51(2):95-101. PubMed ID: 10429419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single, immediate postoperative instillation of chemotherapy in non-muscle invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials using different drugs.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Oncotarget; 2016 Jul; 7(29):45479-45488. PubMed ID: 27323781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravesical chemotherapy and chemoprevention of superficial, low grade, low stage bladder carcinoma.
    Koontz WW
    Semin Oncol; 1979 Jun; 6(2):217-9. PubMed ID: 113878
    [No Abstract]   [Full Text] [Related]  

  • 26. [Intravesical instillation of epirubicin in the prophylactic treatment of recurrent superficial bladder cancer].
    Kobayashi M; Sugaya Y; Yuzawa M; Morita T; Kobayashi Y; Tokue A
    Hinyokika Kiyo; 1998 Dec; 44(12):861-4. PubMed ID: 10028430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Short-term versus long-term chemoprevention of recurrence with Epodyl following transurethral resection of superficial urinary bladder cancer].
    Flamm J; Kühnel W; Dona S
    Urologe A; 1989 Mar; 28(2):99-102. PubMed ID: 2655259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant intravesical mitoxantrone versus recombinant interferon-alpha after transurethral resection of superficial bladder cancer: a randomized prospective study.
    Papatsoris AG; Deliveliotis C; Giannopoulos A; Dimopoulos C
    Urol Int; 2004; 72(4):284-91. PubMed ID: 15153724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J
    Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A controlled study of intravesical epirubicin with or without alpha 2b-interferon as prophylaxis for recurrent superficial transitional cell carcinoma of the bladder. Finnish Multicentre Study Group.
    Raitanen MP; Lukkarinen O
    Br J Urol; 1995 Dec; 76(6):697-701. PubMed ID: 8535711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeat transurethral resection lowers recurrence rates in T1 bladder tumors, even after intravesical mitomycin C.
    Oosterlinck W
    Nat Clin Pract Urol; 2006 Nov; 3(11):582-3. PubMed ID: 17088923
    [No Abstract]   [Full Text] [Related]  

  • 32. Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach.
    Schulze M; Stotz N; Rassweiler J
    J Endourol; 2007 Dec; 21(12):1533-41. PubMed ID: 18186695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Instillation chemotherapy with peplomycin in superficial bladder cancer: clinical study on the effects of the direct antitumor activity and of the prophylaxis of recurrence].
    Sonoda T; Osafune M; Matsuda M; Usami M
    Hinyokika Kiyo; 1988 Mar; 34(3):574-81. PubMed ID: 2455442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of intravesical chemoprophylaxis of epirubicin after transurethral resection of bladder tumors. Tottori University Oncology Group.
    Watanabe N; Miyagawa I; Higasibori Y; Nakahara T; Sumi F; Ishida G; Abe B; Inoue A; Hanamoto N
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S57-9. PubMed ID: 7994788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Point. Routine use of postoperative intravesical chemotherapy after TURBT-should it be done?
    Soloway MS; Arianayagam M
    Urology; 2010 Oct; 76(4):794-6. PubMed ID: 20932403
    [No Abstract]   [Full Text] [Related]  

  • 36. Does intravesical chemotherapy prevent invasive bladder cancer?
    Green DF; Robinson MR; Glashan R; Newling D; Dalesio O; Smith PH
    J Urol; 1984 Jan; 131(1):33-5. PubMed ID: 6418897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reducing recurrence in non-muscle-invasive bladder cancer by systematically implementing guideline-based recommendations: effect of a prospective intervention in primary bladder cancer patients.
    Sörenby A; Baseckas G; Bendahl PO; Brändstedt J; Håkansson U; Nilsson S; Patschan O; Tinzl M; Wokander M; Liedberg F; Gudjonsson S
    Scand J Urol; 2019; 53(2-3):109-115. PubMed ID: 31064253
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinicopathological evaluation of repeated courses of intravesical bacillus Calmette-Guerin instillation for preventing recurrence of initially resistant superficial bladder cancer.
    Okamura T; Tozawa K; Yamada Y; Sakagami H; Ueda K; Kohri K
    J Urol; 1996 Sep; 156(3):967-71. PubMed ID: 8709375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma.
    Colombo R; Da Pozzo LF; Salonia A; Rigatti P; Leib Z; Baniel J; Caldarera E; Pavone-Macaluso M
    J Clin Oncol; 2003 Dec; 21(23):4270-6. PubMed ID: 14581436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 4th study of prophylactic intravesical chemotherapy with adriamycin in the treatment of superficial bladder cancer: the experience of the Japanese Urological Cancer Research Group for Adriamycin.
    Matsumura Y; Akaza H; Isaka S; Kagawa S; Koiso K; Kotake T; Machida T; Niijima T; Obata K; Ohashi Y
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S10-4. PubMed ID: 1394809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.